![](/img/cover-not-exists.png)
PDB4 THE HEALTH-ECONOMIC IMPLICATIONS OF THE “IRBESARTAN IN DIABETIC NEPHROPATHY TRIAL” (IDNT) IN FRANCE AND BELGIUM
AJ Palmer, L Annemans, S Roze, M Lamotte, C Guilhaume, S Gabriel, P Carita, R Chen, T Simon, R Rodby, DJ CordonnierVolume:
5
Year:
2002
Language:
english
DOI:
10.1016/s1098-3015(10)61441-6
File:
PDF, 66 KB
english, 2002